Hovione Cork

Manufacturing Plant

Unique combination of capacity and high-quality people.

The focus of the Hovione Cork site is Contract Development and Manufacturing offering both drug substance and particle engineering. The plant has been regularly inspected by the FDA and the Health Products Regulatory Authority (From a HSEE perspective the site has been regularly inspected by the local Health and Safety Authority and the Environmental Protection Agency.

The site prides itself on its project teams capability to deliver multiple projects with accelerated timelines.

“Hovione Cork is unique, it combines hard to find capacity and quality people”

US Biotech, West Coast

The site has extensive facilities for Drug Substance manufacturing with approximately 430 cubic meters of cGMP manufacturing capacity ranging in scale from 2.5m3 to 16m3 across two chemistry buildings. In addition, the site has both ultrafiltration and nanofiltration capabilities in both chemistry buildings. Equipment is flexible via manifold connectivity and multipurpose and the potential for up to 12 discrete process trains across two chemistry buildings with the potential for future expansion. The site has experience across a wide variety of chemistries.

The site houses the largest commercial pharmaceutical spray dryer available on the market, a Niro PSD-5, which is particularly suited for large volume products. A PSD4 equipment train is currently being installed and going live in 2024.

The site is expanding its offering and capabilities for process development and industrialization with the expansion of the Process R&D group in 2024. A highly potent small scale equipment facility to support clinical trial and Registration campaigns is also planned for the site. 
 

Areas of Focused Expertise

The site has leading capabilities and physical assets in the following areas:

  • Cryogenic (Volume 8000L to 10,000L, Temperature Range -150 to 120ºC)
  • Metal catalyst handling and Hydrogenation (Volume 2500L to 6000L, Pressure Rating 6 to 12 bar)
  • Large scale spray drying (PSD5 and PSD4)
  • Pyrophoric material handling (2 stations)
  • Ultra filtration (2 UF skids per building with 160m2 surface area per skid) and Nano filtration unts.
     

For details about production equipment – click here

Operations

  • The Cork plant operates 24 hours a day 7 days a week.
  • Quality Control labs supports production 24 hours a day 7 days a week.
  • Plant maintenance shutdown period takes place for 2 to 3 weeks in August.

 

 

10 years in Cork, 60 years in the world

In 2019 Hovione celebrated its 10th anniversary at the Cork site in Ireland. Learn more.

 

For inquiries about Hovione Cork, kindly fill the form below.

News

Lisbon, Portugal – Hovione, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, Hovione joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At Hovione, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of Hovione. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” Hovione will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with Hovione’s sustainability ambitions.  Hovione remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024
Manufacturing Plant
Address

Hovione Ltd
Loughbeg
Ringaskiddy
Co. Cork
Ireland
P43 DY23
Tel.: +353 21 451 2856
Fax: +353 21 437 8697
Email: contact@hovione.com
DUNS Nr: 985003840
Location: 51°49'20-01" N  8°18'28.23" W

Health Products Regulatory Authority logo | Hovione
FDA logo | Hovione
HSA - locations
EPA Ireland Logo
EcoVadis - locations
Business in the community Ireland Member logo | Hovione
Business Working Responsibility Mark logo | Hovione

Other Locations

Hovione Hong Kong

Office
Address

Hovione Holding Asia Limited
Aubin House, 11th Floor
171-172 Gloucester Road
Wanchai
Hong Kong SAR
Tel.: +852 2891 1836
Fax: +852 2891 0943 

Hovione India

Office
Address

Hovione Holding Limited
C/o WeWork, 2nd floor,
Oberoi Commerz - II,  1,
Off Western Express Highway,
Oberoi Garden City, Goregaon East, Mumbai, Maharashtra 400063
India
Tel.: +919 004 261 523

Hovione Beijing

Office
Address

Hovione (Shanghai) Pharma Technology Limited Beijing Branch
Room 1003-1, 10/F, Sanyuan NEO Xinjing Building, Building 18, No. 5 Shuguang Xili, Chaoyang District, Beijing, China
Tel.: +86-18500027185
Tel.: +86-19931153253 

contact@hovione.com